Massimo Pieri
Impact in
- Neurology top 2%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
-
- Neuroscience and Neuropharmacology Research
Papers in
- Neurology 34
- Parkinson's Disease Mechanisms and Treatments 20
- Amyotrophic Lateral Sclerosis Research 15
-
- SARS-CoV-2 and COVID-19 Research 21
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 detection and testing 13
- Co-authors
- Cristina Zona (27 shared papers)Sergio Bernardini (83 shared papers)Irene Carunchio (11 shared papers)Federica Albo (4 shared papers)Nicola Biagio Mercuri (15 shared papers)Marco Ciotti (16 shared papers)Alessandro Marroni (19 shared papers)Marzia Nuccetelli (17 shared papers)
- Journals
- International Journal of Molecular Sciences (7 papers)International Immunopharmacology (6 papers)Neuropharmacology (4 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (4 papers)Clinica Chimica Acta (3 papers)
- Partner nations
- ItalyUnited StatesQatar
In The Last Decade
Massimo Pieri
153 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 147
- Neurology 757
- Cellular and Molecular Neuroscience 491
- Genetics 270
- Infectious Diseases 452
- Developmental Neuroscience 62
Countries citing papers authored by Massimo Pieri
This map shows the geographic impact of Massimo Pieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Pieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Pieri more than expected).
Fields of papers citing papers by Massimo Pieri
This network shows the impact of papers produced by Massimo Pieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Pieri. The network helps show where Massimo Pieri may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Pieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 178 | |
| 2 | 2008 | 122 | |
| 3 | 2003 | 121 | |
| 4 | 2007 | 110 | |
| 5 | 2021 | 99 | |
| 6 | 2021 | 94 | |
| 7 | 2015 | 91 | |
| 8 | 2015 | 79 | |
| 9 | 2007 | 75 | |
| 10 | 2013 | 74 | |
| 11 | 2020 | 70 | |
| 12 | 2021 | 70 | |
| 13 | 2009 | 62 | |
| 14 | 2004 | 55 | |
| 15 | 2017 | 53 | |
| 16 | 2006 | 50 | |
| 17 | 2007 | 50 | |
| 18 | 2021 | 48 | |
| 19 | 2015 | 45 | |
| 20 | 2007 | 43 |
About Massimo Pieri
Massimo Pieri is a scholar working on Neurology, Infectious Diseases, Cellular and Molecular Neuroscience, Pulmonary and Respiratory Medicine and Physiology, having authored 163 papers that have together received 3.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (21 papers), Parkinson's Disease Mechanisms and Treatments (20 papers), COVID-19 Clinical Research Studies (18 papers), Cardiovascular and Diving-Related Complications (18 papers), Amyotrophic Lateral Sclerosis Research (15 papers), SARS-CoV-2 detection and testing (13 papers), Neuroscience and Neuropharmacology Research (11 papers) and Alzheimer's disease research and treatments (9 papers). The work is most often cited by research in Neurology (757 citations), Cellular and Molecular Neuroscience (491 citations), Genetics (270 citations), Infectious Diseases (452 citations) and Developmental Neuroscience (62 citations). Massimo Pieri has collaborated with scholars based in Italy, United States and Qatar. Frequent co-authors include Cristina Zona, Sergio Bernardini, Irene Carunchio, Federica Albo, Nicola Biagio Mercuri, Marco Ciotti, Alessandro Marroni, Marzia Nuccetelli, Danilo Cialoni and Marilena Minieri. Their work appears in journals such as International Journal of Molecular Sciences, International Immunopharmacology, Neuropharmacology, Clinical Chemistry and Laboratory Medicine (CCLM) and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.